Committee members play a critical role in providing FDLI with subject-matter and editorial advisory expertise. Service on committees is limited to FDLI members and government employees. The nomination process for committee service opens each fall.

Get Involved: Become an FDLI Member

Committee Participation

  • Committee service requires a commitment of between 5 – 10 hours a year. The committees meet by video, email, and conference call.
  • Terms for FDLI Committees are one year, generally January – December. Some committees encourage members to serve multiple terms.
  • In addition to supporting FDLI, committee participation allows you the opportunity to connect with other FDLI members from across the community.

For questions about the FDLI Committees or the nominations process, contact Claire Day, Educational Programs Coordinator.

2019 Call for Committee Nominations – Now Closed

FDLI members are invited to nominate themselves or someone else. If nominating someone else, please ensure that the person has agreed to be nominated. If you are nominating yourself for more than one committee, please submit a separate form for each committee.

Committees currently seeking nomination include:

  • Academic Programs Committee
  • Advertising and Promotion Conference Planning Committee
  • Austern Writing Awards Committee
  • Enforcement, Litigation, and Compliance Conference Planning Committee
  • Food Advertising, Labeling, and Litigation Conference Planning Committee
  • Food and Drug Law Journal Editorial Advisory Board
  • Medical Products Committee
  • Publications Peer Review Committee
  • Tobacco and Nicotine Products Committee

All nominations must be submitted by October 18. Committee selections will be communicated early December.

Current Committees

Academic Programs Committee helps FDLI support scholarship in the food and drug law field.

  • Laurie J. Beyranevand, Vermont Law School
  • Marsha A. Echols, Howard Univserity
  • Victoria Girard, Georgetown University
  • Lewis Grossman, American University
  • Sam Halabi, University of Missouri Columbia School of Law
  • Ralph Hall, Leavitt Partners, LLC
  • Stuart Kim, Cardinal Health, Inc.
  • Erika F. Lietzan, University of Missouri Columbia School of Law
  • Dorthy Linvill-Neal, Novartis Pharmaceuticals Corporation
  • Jordan Paradise, Loyola University
  • Gael Tisack, Wichita State University

Advertising and Promotion Conference Planning Committee helps FDLI to provide timely and relevant programming regarding advertising and promotion trends, emerging issues, and policy developments.

  • Laura Brown (Staff Liaison), FDLI
  • Kellie Combs, Ropes & Gray LLP
  • Dale Cooke, PhillyCooke Consulting
  • Lisa Dwyer, King & Spalding LLP
  • Mark Gaydos, Sanofi
  • Kelly Goldberg, PhRMA
  • Wayne Pines, APCO Worldwide
  • Jennifer Romanski, Porzio Bromberg & Newman, P.C.
  • Lucy Rose, Lucy Rose & Associates, LLC
  • Paul Savidge, Spark Therapeutics
  • Ellen Schumacher, Bristol-Myers Squibb Company

Annual Conference Planning Committee helps FDLI develop the premier conference for the food and drug law industry.

  • Laura Brown (Staff Liaison), FDLI
  • Carla Cartwright (Co-Chair), Johnson & Johnson
  • Neil DiSpirito (Co-Chair), Ballard Spahr LLP
  • Stacey Gagosian, Truth Initiative
  • Martin Hahn, Hogan Lovells US LLP
  • Lori Hirsch, Bristol-Myers Squibb
  • John Manthei, Latham & Watkins LLP
  • Jeff Nelligan, FDA – ORA
  • Amy Norris, Clif Bar & Company
  • Jeannie Perron, Covington & Burling LLP
  • Cassie Scherer, Medtronic
  • William Schultz, Zuckerman Spaeder LLP
  • Julie Tierney, FDA – OBER
  • Michael Werner, Holland & Knight LLP

Audit Committee oversees and evaluates the management’s control over financial reporting. This committee is led by and reports to the FDLI Board of Directors. 

  • Hayley Carpenter (Staff Liaison), FDLI
  • Daniel Kracov (Chair), Arnold & Porter LLP
  • Steven H. Armstrong, EAS Consulting Group, LLC
  • Cathy Burgess, Alston & Bird LLP
  • Stuart Pape, Polsinelli PC

Austern Writing Awards Committee fosters the next generation of professionals in the food and drug law field.  

  • Hayden Galante (Staff Liaison), FDLI
  • Melissa Card-Abela, Michigan State University
  • Ariella Cohen, The Pew Charitable Trusts
  • Yolande Dufresne, Torys LLP
  • Jane Kalinina, Foley Hoag LLP
  • Kristen Klesh, Venable LLP
  • Chia-Feng Lu, Baker & McKenzie
  • Caitlyn Ozier, King & Spalding LLP
  • Sung Park,, LLC / Benjamin L. England & Associates, LLC
  • Carrie A. Scrufari, New York Department of State
  • Jennifer Thomas, Hyman Phelps & McNamara PC

California Programs Planning Committee helps FDLI develop programming to be offered in California.

  • Laura Brown (Staff Liaison), FDLI
  • Khara Minter (Staff Liaison), FDLI
  • Wade Ackerman, Covington & Burling LLP
  • Heather Howell, NSF International
  • Vinita Kailasanath, Arnold & Porter LLP
  • Emily Marden, Sidley Austin LLP
  • Kai Peters, Gordon & Rees LLP
  • Deborah Tolomeo, Genentech, Inc.
  • Ian M. Pearson, Jones Day

Enforcement, Litigation, and Compliance Conference Planning Committee helps FDLI cover the latest trends and changes in enforcement and compliance.

  • Laura Brown (Staff Liaison), FDLI
  • Deborah Autor, Mylan Pharmaceuticals, Inc.
  • Hannah Bornstein, Nixon Peabody LLP
  • John Garvey, Compliance Architects LLC
  • George Karavetsos, DLA Piper LLP
  • Mark Mansour, Foley Hoag LLP
  • Matthew Newcomer, Post & Schell, P.C.
  • Cynthia Schnedar, Greenleaf Health, Inc.
  • Howard Sklamberg, Akin Gump Strauss Hauer & Feld LLP
  • Kimberly Trautman, NSF International
  • Anne Walsh, Hyman Phelps & McNamara, PC
  • Jessica Zeller, FDA – ORA

Finance Committee oversees FDLI’s financial affairs, including budget formulation and execution, and investment portfolio management. This committee is led by and reports to the FDLI Board of Directors. 

  • Frederick R. Ball (Chair), Duane Morris LLP
  • Scott M. Melville (Board Liaison), Consumer Healthcare Products Association (CHPA)
  • Hayley Carpenter (Staff Liaison), FDLI
  • Amy Norris, Clif Bar & Company
  • Peter Pitts, Center for Medicine in the Public Interest
  • Stuart TenHoor, Stuart TenHoor Legal Search

Food and Dietary Supplements Committee helps FDLI provide the food and dietary supplement industries with timely and relevant programming, including the Food Advertising, Labeling, and Litigation Conference and Food Enforcement Conference. (Disbanding December 31, 2018)

  • Paige Samson (Staff Liaison), FDLI
  • Rend Al-Mondhiry, Amin Talati & Upadhye, LLP
  • Steven H. Armstrong, EAS Consulting Group, LLC
  • Sandra Eskin, The Pew Charitable Trusts
  • August T. Horvath, Foley Hoag LLP
  • Alissa Jijon, U.S. Pharmacopeia
  • Meredith Olearchik, Campbell Soup Company
  • John Packman, The Coca-Cola Company
  • Stuart Pape, Polsinelli PC
  • Jason Sapsin, Faegre Baker Daniels LLP
  • Brooke Schumm, Daneker, McIntire, Schumm
  • Suzanne Trigg, Haynes and Boone LLP
  • Amanda Triner, FDA – CFSAN
  • Kurt D. Weaver, Womble Bond Dickinson LLP

Food Advertising, Labeling, and Litigation Conference Planning Committee helps FDLI to provide updates on the most pertinent aspects and trends in advertising, labeling, and litigation. (Launching January 1, 2019)

Food Enforcement and Compliance Conference Planning Committee helps FDLI to cover recent changes and updates in food enforcement and compliance. (Launching January 1, 2019)

Food and Drug Law Journal Editorial Advisory Board provides peer review of manuscript submissions, advises on content, and serves as a resource for our student editors at Georgetown University Law Center.

  • Judy Rein (Staff Liaison), FDLI
  • Anthony J. Anscombe, Steptoe & Johnson LLP
  • Barbara A. Binzak Blumenfeld, Buchanan Ingersoll & Rooney PC
  • Marie Boyd, University of South Carolina
  • Catherine Clements, Eli Lilly and Company
  • Thomas Colonna, Johns Hopkins University
  • Brian A. Dahl, Dahl Compliance Consulting LLC
  • Jeffrey K. Francer, Association of Accessible Medicines
  • Robert C. Giddings, Hutchison PLLC
  • Abraham Gitterman, Arnold & Porter LLP
  • Kimberly J. Gold, Norton Rose Fulbright Canada LLP
  • Peter B. Hutt II, Akin Gump Strauss Hauer & Feld LPP
  • William Janssen, Charleston School of Law
  • John Johnson, LLC, Benjamin L. England & Associates LLC
  • Alan C. Katz, toxCel, LLC
  • Sara Koblitz, Hyman Phelps & McNamara PC
  • Natasha Leskovsek, Cooley LLP
  • Priya Mannan, Novartis Pharmaceuticals Corporation
  • Alexandra Marzelli, FDA – OC
  • Alan Minsk, Arnall Golden Gregory LLP
  • Nicole Negowetti, Harvard Law School
  • James T. O’Reilly, University of Cincinatti
  • Joseph A. Page, Georgetown University
  • Sandra Retzky, FDA – CTP
  • Jessica Ringel, King & Spalding LLP
  • Sarah Roller, Kelley Drye & Warren LLP
  • Marc J. Scheineson, Alston & Bird LLP
  • Jodi Schipper, Federal Government
  • David C. Spangler, Consumer Healthcare Products Association (CHPA)
  • Christopher G. Van Gundy, Keller and Heckman LLP
  • Andrew Wasson, Haug Partners LLP
  • James W. Woodlee, Kleinfeld, Kaplan & Becker
  • Emily Wright, Pfizer, Inc.
  • Kimberly F. Yocum, Ideaish
  • Lowell Zeta, Hogan Lovells US LLP
  • Patricia Zettler, Georgia State University

Medical Products Committee helps FDLI provide programming to meet the needs of the medical products community.  

  • Laura Brown (Staff Liaison), FDLI
  • Paul Gadiock, Arent Fox LLP
  • Robert Guzman, Thompson Hine LLP
  • Sonali P. Gunawardhana, Shook, Hardy & Bacon
  • Chad Landmon, Axinn, Veltrop & Harkrider LLP
  • Mark Levy, Eckert Seamans Cherin & Mellott, LLC
  • John McShane, Validant
  • Vernessa T. Pollard, McDermott Will & Emery
  • Jeffrey K. Shapiro, Hyman, Phelps & McNamara, PC
  • Lance Shea, BakerHostetler
  • Deborah Shelton, McCarter & English LLP
  • Sarah H. Stec, Squire Patton Boggs LLP
  • Rachel Turow, TEVA Pharmaceutical USA, Inc.

New to Food and Drug Law Planning Committee assists FDLI in creating educational programming and networking opportunities for those new to food and drug law.

  • Paige Samson (Staff Liaison), FDLI
  • Amy Arthur, Junior Associate, Pinney Associates, Inc.
  • Shelby Buettner, Associate, McDermott Will & Emery
  • Ariella Cohen, Associate, Health Care Products, The Pew Charitable Trusts
  • Delia Deschaine, Senior Associate, Hogan Lovells US LLP
  • Steven Gonzalez, Associate, Polsinelli PC
  • Rachael Hunt, Attorney, Hyman, Phelps & McNamara, PC
  • Elizabeth Mulkey, Associate, Arnall Golden Gregory LLP
  • Megan Robertson, Associate, Epstein Becker & Green, PC
  • Shane Schwartz, Corporate Attorney, Otsuka America Pharmaceuticals, Inc.
  • Steven Tjoe, Associate, Goodwin Procter LLP

Publications Peer Review Committee provides manuscript review and editorial feedback for Update magazine, electronic resources, and book chapters. 

  • Judy Rein (Staff Liaison), FDLI
  • Carolyn Alenci, Duane Morris LLP
  • Jacqueline Berman, Morgan, Lewis & Brockius LLP
  • Jacqueline Chan, Kleinfeld, Kaplan & Becker
  • Sarah diFrancesca, Cooley LLP
  • Bridget C.E. Dooling, Office of Management & Budget
  • Maya Florence, Skadden, Arps, Slate, Meagher & Flom LLP
  • Shelly Garg, Sandler, Travis & Rosenberg, P.A.
  • Colleen M. Heisey, Jones Day
  • Gail Javitt, Epstein Becker Green, PC
  • James R. Johnson, Hogan Lovells US LLP
  • Susan Lee, Hogan Lovells US LLP
  • Kari K. Loeser, Jazz Pharmaceuticals, Inc.
  • Kevin Madagan, Reed Smith LLP
  • Timothy Moore, BD
  • Jessica O’Connell, Covington & Burling LLP
  • Nneka C. Onwudiwe, FDA – CDER (serving in a personal capacity)
  • Sudhanshu Patwardhan, British American Tobacco
  • Evangelia Pelonis, Keller and Heckman LLP
  • Kai Peters, Gordon & Rees LP
  • Barry Schaevitz, Fox Rothschild LLP
  • Laura Sim, Amgen Inc.
  • Genevieve M. Spires, Buchanan Ingersoll & Rooney PC
  • Smitha G. Stansbury, King & Spalding LLP
  • Sara Zborovski, Norton Rose Fulbright Canada LLP

Publications Advisory Board provides strategic input on developing book projects, identifying editors and authors, and the overall content of the FDLI publications program.

  • Judy Rein (Staff Liaison), FDLI
  • Ricardo Carvajal, Hyman, Phelps & McNamara PC
  • Joanne Hawana, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 
  • Marian J. Lee, Gibson, Dunn & Crutcher LLP
  • Laurie Lenkel, FDA – OC
  • Geoffrey Levitt, Pfizer, Inc.
  • Lynn Tyler, Barnes & Thornburg LLP

Tobacco and Nicotine Products Committee ensures that tobacco programs bring diverse stakeholders together to have high-level discussions on tobacco products regulation and policy.  

  • Paige Samson (Staff Liaison), FDLI
  • David Abrams, New York University
  • Scott Ballin, Independent Consultant
  • Donald Becker, Turning Point Brands, Inc.
  • Dean R Cirotta, EAS Consulting Group, LLC
  • Azim Chowdhury, Keller and Heckman LLP
  • Marc Firestone, Philip Morris International
  • Carole Folmar, ITG Brands
  • Robyn Gougelet, Senior Associate, Pinney Associates, Inc.
  • Bryan M. Haynes, Troutman Sanders LLP
  • Dennis Henigan, Campaign for Tobacco-Free Kids
  • Kathleen Hoke, University of Maryland Law School
  • Eshael Johnson, FDA – CTP
  • Jose Luis Murillo, Altria Client Services LLC
  • Ray Niaura, New York University
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Valerie Solomon, RAI Services Company
  • Donna Vallone, Truth Initiative